صفحه اصلی » همه » پیش بینی سهام » Coherus Oncology Inc. Common Stock پیش بینی

Coherus Oncology Inc. Common Stock پیش بینی: فردا, هفته, ماه, 5 سال

به روز شد: April 22 · 2026 at 07:03 UTC

From

▼ -8.54%Market Cap $280.68M · Technical analysis Bearish · Focus area Price + volatility

خلاصه پیش بینی

بازه زمانی	قیمت پیش بینی شده	گذشته	تاریخی	بینش
فردا	$1.86 ▲ +2.03%	دیروز	$1.80 ▼ -0.85%	Tomorrow's Coherus Oncology Inc. Common Stock (CHRS) setup is anchored to $1.82 and targets $1.86 (+2.03%). The near-term read is upside; watch $1.87 / $1.77 because daily realized volatility is about 8.00%.
Tomorrow's Coherus Oncology Inc. Common Stock (CHRS) setup is anchored to $1.82 and targets $1.86 (+2.03%). The near-term read is upside; watch $1.87 / $1.77 because daily realized volatility is about 8.00%.
هفته	$1.93 ▲ +6.31%	هفته گذشته	$1.77 ▼ -2.65%	The 7-day Coherus Oncology Inc. Common Stock model moves from $1.77 to $1.93 (+6.31%). It gives upside momentum context for this stock, so breaks around $1.87 / $1.77 matter more than a single tick.
The 7-day Coherus Oncology Inc. Common Stock model moves from $1.77 to $1.93 (+6.31%). It gives upside momentum context for this stock, so breaks around $1.87 / $1.77 matter more than a single tick.
ماه	$2.06 ▲ +13.45%	ماه گذشته	$1.72 ▼ -5.65%	The 1-month Coherus Oncology Inc. Common Stock target is $2.06 (+13.45%), compared with the live reference near $1.82. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk.
The 1-month Coherus Oncology Inc. Common Stock target is $2.06 (+13.45%), compared with the live reference near $1.82. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk.
سال	$2.26 ▲ +24.14%	سال گذشته	$1.64 ▼ -10.14%	The 1-year Coherus Oncology Inc. Common Stock scenario points to $2.26 (+24.14%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates.
The 1-year Coherus Oncology Inc. Common Stock scenario points to $2.26 (+24.14%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates.
5 سال	$2.72 ▲ +49.20%	5 سالها پیش	$1.44 ▼ -20.66%	The 5-year Coherus Oncology Inc. Common Stock view is $2.72 (+49.20%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path.
The 5-year Coherus Oncology Inc. Common Stock view is $2.72 (+49.20%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path.

فردا$1.86▲ +2.03%

دیروز$1.80▼ -0.85%

Tomorrow's Coherus Oncology Inc. Common Stock (CHRS) setup is anchored to $1.82 and targets $1.86 (+2.03%). The near-term read is upside; watch $1.87 / $1.77 because daily realized volatility is about 8.00%.

هفته$1.93▲ +6.31%

هفته گذشته$1.77▼ -2.65%

The 7-day Coherus Oncology Inc. Common Stock model moves from $1.77 to $1.93 (+6.31%). It gives upside momentum context for this stock, so breaks around $1.87 / $1.77 matter more than a single tick.

ماه$2.06▲ +13.45%

ماه گذشته$1.72▼ -5.65%

The 1-month Coherus Oncology Inc. Common Stock target is $2.06 (+13.45%), compared with the live reference near $1.82. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk.

سال$2.26▲ +24.14%

سال گذشته$1.64▼ -10.14%

The 1-year Coherus Oncology Inc. Common Stock scenario points to $2.26 (+24.14%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates.

5 سال$2.72▲ +49.20%

5 سالها پیش$1.44▼ -20.66%

The 5-year Coherus Oncology Inc. Common Stock view is $2.72 (+49.20%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path.

Risk notice:This forecast is informational only, not financial advice; accuracy depends on volatility, liquidity, macro events, and other external factors.

نمودار قیمت

تاریخیپیش بینیصعودینزولی

تحلیل فنی

Neutral

صعودی

خنثی

نزولی

شاخص های کلیدی

شاخص	ارزش	سیگنال
Price	$1.82	Mid
Daily Change	-8.54%	Below
Volatility Cap	20.0%	Mid
Confidence	76%	Above
Data Source	nasdaq-screener	Mid

داده های تاریخی

Current$1.82

Daily Change-8.54%

Market Cap$280.68M

Sourcenasdaq-screener

Current	$1.82	Daily Change	-8.54%
Market Cap	$280.68M	Source	nasdaq-screener

سطوح پشتیبانی و مقاومت

$1.77پشتیبانی کنید 1

$1.82فعلی

$1.87مقاومت 1

Support and resistance are estimated from the trusted current price until deeper historical data is available.

نقاط عطف قیمت

سطوح کلیدی و بافت تاریخی

Current$1.82Live reference price

Used as the anchor for generated forecast calculations.

Next Month$2.06Model projection+13.45%

Directional scenario based on capped drift.

دقت پیش بینی

مدل ما چگونه عمل کرده است

76%

جهت دار

Generated market-data forecast

This page uses live catalog market data and conservative volatility caps. It is informational, not financial advice.

📊

الگوریتم ما هر هفته با استفاده از آخرین اقدام قیمت، رژیم نوسانات و سیگنال‌های نشانگر کالیبره می‌شود. دقت در بازه زمانی متفاوت است - حرکت کوتاه مدت قابل اعتمادتر از پیش بینی های بلند مدت است.

Short term

76%

Direction confidence

Long term

Lower

Forecast uncertainty rises with horizon

سناریوهای سرمایه گذاری

اگر امروز $1,000 را در CHRS سرمایه گذاری کنید

Bullish Scenario

$1.91

+5.00% from current

قیمت هدف$1.91

سناریوUpside momentum

احتمال62%

Base Scenario

$2.06

+13.45%

قیمت هدف$2.06

سناریوCapped drift

احتمال70%

Bearish Scenario

$1.73

-5.00% from current

قیمت هدف$1.73

سناریوVolatility drawdown

احتمال24%

اساس: Scenario model combines current spot price, recent market direction, and conservative asset-class volatility caps.

عوامل پیش بینی

Market Structure

Price structure reflects the latest momentum regime and support/resistance interaction.

Momentum Bullish · 79/100

24H drift+2.03%

7D drift+6.31%

30D drift+13.45%

Technical Signals

Signals combine RSI, MACD, and moving average stacks to estimate short-term direction.

Mixed — Watching · 50/100

RSIn/a

MACDn/a

MA stackn/a

Macro Context

Rates, dollar strength, and cross-asset risk appetite influence medium-term paths.

Risk-On Tentative · 75/100

1M outlook+13.45%

1Y outlook+24.14%

5Y outlook+49.20%

سوالات متداول

Q What is the Coherus Oncology Inc. Common Stock (CHRS) forecast for tomorrow?

Using the latest BeCoin market snapshot (April 22 · 2026 at 07:03 UTC), Coherus Oncology Inc. Common Stock is projected near $1.86 versus the current reference around $1.82. That implies a modeled move of +2.03% over the next day, with realized prices still sensitive to intraday volatility.

Q What does the 7-day stock outlook suggest for CHRS?

The weekly Coherus Oncology Inc. Common Stock model points to $1.93, which maps to an expected drift of +6.31% from current conditions. This horizon reacts quickly to momentum shifts, so support/resistance breaks can change the path faster than long-term targets.

Q How should I read the Coherus Oncology Inc. Common Stock 1-month and 1-year targets?

The Coherus Oncology Inc. Common Stock 1-month target is $2.06 (+13.45%), while the 1-year target is $2.26 (+24.14%). The monthly view tracks prevailing trend pressure, and the yearly view reflects broader cycle assumptions shaped by price momentum, liquidity, and company-specific risk.

Q Why does the Coherus Oncology Inc. Common Stock 5-year scenario differ from short-term rows?

The Coherus Oncology Inc. Common Stock long-horizon scenario sits near $2.72 with a modeled change of +49.20%. It compounds cycle-continuation assumptions over time, so it should be treated as a scenario envelope rather than a precise endpoint.

Q Where are CHRS support and resistance zones right now?

For Coherus Oncology Inc. Common Stock, nearest resistance is around $1.77, while nearest support is around $1.87. A clean break above resistance improves continuation odds, while repeated closes under support raise downside risk.

Q How fresh is the Coherus Oncology Inc. Common Stock market snapshot?

The displayed stock snapshot is labeled April 22 · 2026 at 07:03 UTC; the latest observed session range is roughly n/a to n/a. These checkpoints are rebuilt from the market feed so the FAQ, milestones, and support/resistance context stay tied to the same data refresh.